• Earlier this quarter, Palantir Technologies reported second-quarter revenue of US$1.94 billion with a net income margin of 55% and operating margin of 47%, and management raised its 2026 revenue guidance while reiterating expectations for ongoing quarterly profitability.
• The results underscored Palantir’s operating leverage in its AI-focused enterprise software business, as it converted a large share of revenue into profit while expanding its role in custom AI analytics solutions.
• With Palantir’s raised 2026 revenue guidance and strong margins in focus, we’ll now examine how this updates the company’s investment narrative.

Outshine the giants: these 18 early-stage AI stocks could fund your retirement.

Palantir Technologies Investment Narrative Recap

To own Palantir, you need to believe its AI platforms can stay central to how governments and enterprises run critical operations, and that strong profitability can be sustained even as the business scales. The latest quarter’s high margins and raised 2026 revenue guidance support this view, but they do not remove the key near term risk that heavy reliance on U.S. government and commercial demand could become a headwind if budgets or AI deployment priorities shift.

Among recent announcements, the expansion of Palantir’s work with the U.S. Army, where Foundry is serving as the cloud data layer alongside Lattice at the tactical edge, feels especially relevant. This kind of entrenched role in mission critical defense data systems reinforces the current growth catalyst of wider AI adoption in core government accounts, while also highlighting the concentration risk if political or spending priorities change meaningfully from here.

Yet beneath these strong headlines, investors still need to be aware of how concentrated Palantir’s growth is in U.S. customers and what happens if that reliance...

Read the full narrative on Palantir Technologies (it's free!)

Palantir Technologies' narrative projects $10.8 billion revenue and $3.6 billion earnings by 2028. This requires 40.7% yearly revenue growth and about a $2.5 billion earnings increase from $1.1 billion today.

Uncover how Palantir Technologies' forecasts yield a $185.70 fair value, a 3% upside to its current price.

Exploring Other Perspectives

While consensus focuses on robust margins and raised 2026 guidance, the most pessimistic analysts were already assuming revenue of US$17.3 billion and earnings of US$6.2 billion by 2029, yet still saw today’s expectations as stretched, which shows how differently you can interpret the same AI story and why it can be useful to compare several viewpoints before deciding what feels realistic to you.

Explore 54 other fair value estimates on Palantir Technologies - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Palantir Technologies research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Palantir Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Palantir Technologies' overall financial health at a glance.

Ready For A Different Approach?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Find 48 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.